Leonie Goetz1, Irina Jarvers1, Daniel Schleicher1, Kathrin Mikan1, Romuald Brunner1, Stephanie Kandsperger2. 1. Clinic for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Regensburg, Universitätsstraße 84, 93053, Regensburg, Germany. 2. Clinic for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Regensburg, Universitätsstraße 84, 93053, Regensburg, Germany. Stephanie.Kandsperger@medbo.de.
Abstract
BACKGROUND: In social neuroscience, the linkage between the endocrinological system and the etiology and symptomatology of mental health problems has received increasing attention. A particular focus is given to the neuropeptide oxytocin with its anxiolytic and stress-buffering effect and the resulting therapeutic potential for anxiety disorders. Even though anxiety disorders are the most prevalent mental health disorders in childhood and adolescence worldwide, the reactivity of the endogenous oxytocin system to an acute stressor (Trier Social Stress Test, TSST) has so far only been investigated in healthy children. It has been shown that peripheral oxytocin levels increased under psychosocial stress conditions. In the present study, it is hypothesized that the endogenous oxytocin system in children and adolescents suffering from a clinically diagnosed anxiety disorder is dysregulated. Three primary outcome parameters will be analyzed: significant differences between participants with anxiety disorders compared to healthy controls in basal oxytocin levels, varying salivary oxytocin release after stress exposure and the correlation between the cortisol peak/-decrease and oxytocin level over time. Secondary outcome criteria are significant differences in physiological (heart rate) and psychological (perceived stress, anxiety, insecurity, tension) responses. METHODS: The present study is a single-center experimental observation study to investigate the reactivity of the endocrinological system to a psychosocial stressor (TSST). 32 children and adolescents (11-18 years) suffering from anxiety disorder will be compared to a matched healthy control group. After a detailed psychological assessment, saliva samples will be taken to measure oxytocin levels before and after psychosocial stress exposure at eight different time points. Additionally, the stress hormone cortisol will be analyzed according to the same procedure. DISCUSSION: Due to the high prevalence and comorbidity rate with numerous other psychiatric disorders and mental health problems, there is an urgent need to strengthen research in possible neurobiological underpinnings of anxiety disorders. To our knowledge, the proposed experiment is the first study to examine the endocrinological oxytocin and cortisol reaction to an acute psychosocial stressor in children and adolescents with mental health disorders. Trial registration The study is registered in the German Clinical Trials Register since 11 September 2019, DRKS00017793, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017793 .
BACKGROUND: In social neuroscience, the linkage between the endocrinological system and the etiology and symptomatology of mental health problems has received increasing attention. A particular focus is given to the neuropeptide oxytocin with its anxiolytic and stress-buffering effect and the resulting therapeutic potential for anxiety disorders. Even though anxiety disorders are the most prevalent mental health disorders in childhood and adolescence worldwide, the reactivity of the endogenous oxytocin system to an acute stressor (Trier Social Stress Test, TSST) has so far only been investigated in healthy children. It has been shown that peripheral oxytocin levels increased under psychosocial stress conditions. In the present study, it is hypothesized that the endogenous oxytocin system in children and adolescents suffering from a clinically diagnosed anxiety disorder is dysregulated. Three primary outcome parameters will be analyzed: significant differences between participants with anxiety disorders compared to healthy controls in basal oxytocin levels, varying salivary oxytocin release after stress exposure and the correlation between the cortisol peak/-decrease and oxytocin level over time. Secondary outcome criteria are significant differences in physiological (heart rate) and psychological (perceived stress, anxiety, insecurity, tension) responses. METHODS: The present study is a single-center experimental observation study to investigate the reactivity of the endocrinological system to a psychosocial stressor (TSST). 32 children and adolescents (11-18 years) suffering from anxiety disorder will be compared to a matched healthy control group. After a detailed psychological assessment, saliva samples will be taken to measure oxytocin levels before and after psychosocial stress exposure at eight different time points. Additionally, the stress hormone cortisol will be analyzed according to the same procedure. DISCUSSION: Due to the high prevalence and comorbidity rate with numerous other psychiatric disorders and mental health problems, there is an urgent need to strengthen research in possible neurobiological underpinnings of anxiety disorders. To our knowledge, the proposed experiment is the first study to examine the endocrinological oxytocin and cortisol reaction to an acute psychosocial stressor in children and adolescents with mental health disorders. Trial registration The study is registered in the German Clinical Trials Register since 11 September 2019, DRKS00017793, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017793 .
Entities:
Keywords:
Anxiety disorder; Case–control study; Children and adolescents; Cortisol; Oxytocin; Stress mechanisms; Trier social stress test
Authors: Guilherme V Polanczyk; Giovanni A Salum; Luisa S Sugaya; Arthur Caye; Luis A Rohde Journal: J Child Psychol Psychiatry Date: 2015-02-03 Impact factor: 8.982
Authors: Carlos Blanco; Laura B Bragdon; Franklin R Schneier; Michael R Liebowitz Journal: Int J Neuropsychopharmacol Date: 2012-03-21 Impact factor: 5.176
Authors: Jeffrey R Strawn; Laura Geracioti; Neil Rajdev; Kelly Clemenza; Amir Levine Journal: Expert Opin Pharmacother Date: 2018-07 Impact factor: 3.889
Authors: Jordi Alonso; Zhaorui Liu; Sara Evans-Lacko; Ekaterina Sadikova; Nancy Sampson; Somnath Chatterji; Jibril Abdulmalik; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Laura H Andrade; Ronny Bruffaerts; Graça Cardoso; Alfredo Cia; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep M Haro; Yanling He; Peter de Jonge; Elie G Karam; Norito Kawakami; Viviane Kovess-Masfety; Sing Lee; Daphna Levinson; Maria Elena Medina-Mora; Fernando Navarro-Mateu; Beth-Ellen Pennell; Marina Piazza; José Posada-Villa; Margreet Ten Have; Zahari Zarkov; Ronald C Kessler; Graham Thornicroft Journal: Depress Anxiety Date: 2018-01-22 Impact factor: 6.505
Authors: U Ravens-Sieberer; N Wille; S Bettge; M Erhart Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2007 May-Jun Impact factor: 1.513
Authors: Tessa Reardon; Cathy Creswell; Kathryn J Lester; Kristian Arendt; Judith Blatter-Meunier; Susan M Bögels; Jonathan R I Coleman; Peter J Cooper; Einar R Heiervang; Chantal Herren; Sanne M Hogendoorn; Jennifer L Hudson; Robert Keers; Heidi J Lyneham; Carla E Marin; Maaike Nauta; Ronald M Rapee; Susanna Roberts; Silvia Schneider; Wendy K Silverman; Mikael Thastum; Kerstin Thirlwall; Gro Janne Wergeland; Thalia C Eley Journal: Psychol Assess Date: 2019-05-09